Efficiency analysis of multiple sclerosis therapies
Description
In this project, various questions regarding the efficacy of approved multiple sclerosis (MS) therapies were analyzed. This included descriptive analyses of various medical metrics, as well as time-to-event models corrected for real-world biases. The analysis is based on the real-world data of NTD.
Key Data
Projectlead
Deputy Projectlead
Project status
completed, 11/2021 - 09/2022
Funding partner
Third party